Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries.
Schwœbel V, Trébucq A, Kashongwe Z, Bakayoko AS, Kuaban C, Noeske J, Harouna SH, Souleymane MB, Piubello A, Ciza F, Fikouma V, Gasana M, Ouedraogo M, Gninafon M, Van Deun A, Tagliani E, Cirillo DM, Koura KG, Rieder HL. Schwœbel V, et al. Among authors: gasana m. EClinicalMedicine. 2020 Feb 10;20:100268. doi: 10.1016/j.eclinm.2020.100268. eCollection 2020 Mar. EClinicalMedicine. 2020. PMID: 32300732 Free PMC article.
Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.
Trébucq A, Schwoebel V, Kashongwe Z, Bakayoko A, Kuaban C, Noeske J, Hassane S, Souleymane B, Piubello A, Ciza F, Fikouma V, Gasana M, Ouedraogo M, Gninafon M, Van Deun A, Cirillo DM, Koura KG, Rieder HL. Trébucq A, et al. Among authors: gasana m. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):17-25. doi: 10.5588/ijtld.17.0498. Epub 2017 Nov 17. Int J Tuberc Lung Dis. 2018. PMID: 29149917
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.
Ngabonziza JS, Habimana YM, Decroo T, Migambi P, Dushime A, Mazarati JB, Rigouts L, Affolabi D, Ivan E, Meehan CJ, Van Deun A, Fissette K, Habiyambere I, Nyaruhirira AU, Turate I, Semahore JM, Ndjeka N, Muvunyi CM, Condo JU, Gasana M, Hasker E, Torrea G, de Jong BC. Ngabonziza JS, et al. Among authors: gasana m. Int J Tuberc Lung Dis. 2020 Mar 1;24(3):329-339. doi: 10.5588/ijtld.19.0298. Int J Tuberc Lung Dis. 2020. PMID: 32228764
Highly successful treatment outcome of multidrug-resistant and genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains in Rwanda.
Muvunyi CM, Ngabonziza JCS, Uwimana I, Harelimana JD, Mucyo Y, Sebatunzi OR, Muvunyi TZ, Seruyange E, Masaisa F, Mazarati JB, Gasana M. Muvunyi CM, et al. Among authors: gasana m. Trop Med Int Health. 2019 Jul;24(7):879-887. doi: 10.1111/tmi.13245. Epub 2019 Jun 3. Trop Med Int Health. 2019. PMID: 31066112 Free article.
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century.
Ngabonziza JCS, Rigouts L, Torrea G, Decroo T, Kamanzi E, Lempens P, Rucogoza A, Habimana YM, Laenen L, Niyigena BE, Uwizeye C, Ushizimpumu B, Mulders W, Ivan E, Tzfadia O, Muvunyi CM, Migambi P, Andre E, Mazarati JB, Affolabi D, Umubyeyi AN, Nsanzimana S, Portaels F, Gasana M, de Jong BC, Meehan CJ. Ngabonziza JCS, et al. Among authors: gasana m. J Clin Tuberc Other Mycobact Dis. 2022 Jan 24;27:100299. doi: 10.1016/j.jctube.2022.100299. eCollection 2022 May. J Clin Tuberc Other Mycobact Dis. 2022. PMID: 35146133 Free PMC article. Review.
The national burden of influenza-associated severe acute respiratory illness hospitalization in Rwanda, 2012-2014.
Nyamusore J, Rukelibuga J, Mutagoma M, Muhire A, Kabanda A, Williams T, Mutoni A, Kamwesiga J, Nyatanyi T, Omolo J, Kabeja A, Koama JB, Mukarurangwa A, Umuringa JD, Granados C, Gasana M, Moen A, Tempia S. Nyamusore J, et al. Among authors: gasana m. Influenza Other Respir Viruses. 2018 Jan;12(1):38-45. doi: 10.1111/irv.12494. Epub 2017 Dec 2. Influenza Other Respir Viruses. 2018. PMID: 29197152 Free PMC article.
29 results